- $37.66m
- $83.63m
- $272.50m
- 67
- 98
- 23
- 67
Annual income statement for BGSF, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
R2020 December 27th | 2021 December 26th | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 207 | 239 | 313 | 298 | 272 |
| Cost of Revenue | |||||
| Gross Profit | 66 | 80.9 | 112 | 104 | 92.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 208 | 224 | 320 | 282 | 271 |
| Operating Profit | -1.23 | 14.5 | -7.18 | 16.3 | 1.21 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.81 | 13.1 | -13.2 | 14.9 | -3.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.07 | 10.5 | -10.2 | 11.3 | -3.34 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.44 | 14.1 | -10.2 | 25.4 | -3.34 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.44 | 14.1 | -10.2 | 25.4 | -3.34 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.294 | 0.857 | 0.47 | 1.09 | -0.232 |
| Dividends per Share |